This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Quidel (QDEL) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Here's How Much a $1000 Investment in Quidel Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Quidel (QDEL) Stock Moves -0.29%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $99.20, moving -0.29% from the previous trading session.
Zacks.com featured highlights include Sanderson Farms, Quidel, Crown Holdings, Everest Re Group and Eversource Energy
by Zacks Equity Research
Sanderson Farms, Quidel, Crown Holdings, Everest Re Group and Eversource Energy are included in this blog.
Wall Street Analysts Think Quidel (QDEL) Could Surge 52%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 52.1% upside potential for Quidel (QDEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now
by Zacks Equity Research
Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.
5 Stocks With Solid Sales Growth to Buy Amid Market Volatility
by Swayta Shah
Steady sales growth is vital to gauge a company's health and ability to sustain its business. Let's check out Sanderson Farms (SAFM), Quidel (QDEL), Crown Holdings (CCK), Everest Re (RE) and Eversource Energy (ES) that are witnessing top-line growth.
Should Value Investors Buy These Medical Stocks?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cooper Companies (COO) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cooper Companies' (COO) fiscal first-quarter earnings reflect solid segmental performance.
Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat
by Zacks Equity Research
Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.
Patterson Companies (PDCO) Q3 Earnings Beat, Revenues Lag
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal third-quarter 2022 results benefit from strength in the Dental and Animal Health segments.
Cooper Companies (COO) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal first-quarter results are likely to reflect segmental strength.
Find Strong Stocks to Buy in March with New Analyst Coverage
by Benjamin Rains
Investors who decide to stay on the hunt for stocks might want to utilize our new analyst coverage screen to help find potential winners for March and beyond...
What's in Store for Patterson Companies' (PDCO) Q3 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Animal Health segment.
DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) fourth-quarter results benefit from Technologies & Equipment business.
Inari Medical (NARI) Gains 12.5% Despite In-Line Q4 Earnings
by Zacks Equity Research
Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all of its growth drivers.
Are These Medical Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's How Much You'd Have If You Invested $1000 in Quidel a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Cerner (CERN) Q4 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Cerner's (CERN) fourth-quarter results benefit from gains across four of its business units.
LHC Group (LHCG) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Despite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions.
Wall Street Analysts Believe Quidel (QDEL) Could Rally 47%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 46.8% in Quidel (QDEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Quidel (QDEL) Q4 Earnings Top Estimates, Margins Decline
by Zacks Equity Research
Despite robust revenues from COVID-19 products, Quidel (QDEL) records an overall soft Q4 performance.
Quidel (QDEL) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Quidel (QDEL) delivered earnings and revenue surprises of 49.08% and 0.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Quidel's (QDEL) fourth-quarter results are likely to reflect continued strength across its SARS-related products.
Analysts Estimate Quidel (QDEL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.